• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Depression Treatment Advancements

While effective treatments for depression are available Researchers are developing new and more effective ways to treat the condition. This special Research in Context will explore some of the depression in elderly treatment treatment advances.

Psychotherapy helps alleviate depression symptoms by teaching people the skills to handle negative thoughts and feelings. Talk therapy can be done in groups or one-on-1 with a mental health professional.

Precision mental healthcare

The term "precision" means bringing greater precision or accuracy to diagnosis, prevention and treatment methods. For mental health, this can mean many different approaches, including psychotherapy and medications. Many of these approaches concentrate on the symptoms of the disorder rather than the root causes. This can result in treatments that do nothing more than alleviate symptoms, but do not address the underlying factors that lead to mental illness in the first place.

Fortunately, the field of precision mental health is rapidly advancing. It's a similar approach to that used in other healthcare areas, such as incorporating continuous monitoring of key indicators into the clinical practice (e.g. fever, temperature or blood pressure). It also involves combining a variety of sources of data and applying machine learning to aid doctors better understand a patient's individual needs and formulate more efficient treatment strategies.

One example of precision psychiatry is the use of EEG to determine brain activity and help doctors assess a person's ability to participate in cognitive behavioral therapy. A new class of drugs referred to as NMDA receptor inhibitors may alleviate depression symptoms by blocking the neurotransmitter, glutamate, from reaching specific brain cells. The test can also be used to determine drug-gene interaction and prevent unfavorable effects.

Many companies are also experimenting with digital precision medicine, which makes use of objective digital technology to monitor patients remotely and collect real-time information that helps guide their care. For instance, one company is using artificial intelligence to monitor compliance and optimize dosages of medication for their depression patients. These kinds of solutions have the potential to dramatically increase the accessibility and effectiveness of mental healthcare, as well as increase patients' adherence to treatment.

Digital precision psychiatry, specifically, can help people with mental illness overcome the barriers to treatment, especially those who are employed. Johnson & Johnson, for instance, is working with organizations in Singapore to help facilitate the reintegration process of those recovering from depression back into their jobs. This will allow them to keep their jobs, which are essential for the mental health recovery process.

Medication

Many people with depression find that medication helps alleviate their symptoms, particularly when they're suffering from extreme or debilitating symptoms. Antidepressants help restore the balance of neurotransmitters, which are chemical messengers within the brain that regulate mood and emotions. Most antidepressants today are aimed at one of these neurotransmitters by increasing the levels of serotonin. Selective serotonin reuptake inhibits (SSRIs), like Prozac and Zoloft boost the level serotonin, a chemical in the brain. These SNRIs, such as Cymbalta, Effexor and Cymbalta focus on both norepinephrine as well as dopamine. Monoamine oxidase inhibitors such as Wellbutrin focus on only dopamine and norepinephrine.

Most doctors recommend antidepressants for a first form of treatment for depression, as well as some kind of talk therapy. Some of these therapies include cognitive behavioural therapy (CBT), which helps improve the quality of your thoughts and feelings by teaching specific skills, or psychotherapy for interpersonal relations (which is focused on improving relationships). Other treatments, such as electroconvulsive (ECT) therapy and transcranial magnet stimulation (TMS) have also been proven to be effective in treating depression.

However there are some people who do not respond to the first medications prescribed by doctors. A third of people suffering from depression do not get any relief from their initial medication and about 40 percent who begin taking antidepressants cease within three months. The good news is that research has allowed doctors to predict which type of medication will work best for each individual, utilizing blood or MRI tests to determine which receptors are the most affected by depression.

Medication has improved in recent years with a wider range of options and higher doses to help minimize side effects. For instance, the newest antidepressants such as esketamine (Spravato) and Brexanolone (Auvelity) and nefazodone (Sertraline) help to quickly alleviate depression symptoms through affecting glutamate production in the brain.

Clinical trials are underway on other drugs that could alter the method of their use. Vorapaxar, a drug that is currently being tested in humans, targets a distinct part of the brain that's associated with depression treatment without drugs, by blocking NMDA receptors. It's scheduled to be available by 2024. A combination of ketamine with bupropion has also shown potential. It may be more effective in treating depression treatment for elderly that is resistant to treatment.

Psychotherapy

Psychologists have been able to pinpoint certain factors that contribute to depression, such as deficiency in the neurotransmitters serotonin as well as norepinephrine. These chemicals are crucial in managing mood and emotions as well as the overall function of the brain. Medications such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors are the main treatment options. They can help alleviate many of depression-related symptoms such as depressed feelings and fatigue, and also improve appetite, sleep, and energy levels. They are not without adverse effects, which could make them unsuitable to some people.

Psychotherapy can address root causes of depression and help people cope with depression. Different types of therapy have been proven to reduce symptoms, including cognitive behavior therapy and ketamine infusion therapy. In addition, psychotherapy can assist people in developing a healthy way of coping and to manage stressors. However, access to psychotherapy can be limited due to cost or scheduling restrictions, as well as an absence of mental health providers. The recent increase in the telehealth industry has increased access for some people.

The challenge with overcoming depression is finding the right combination of treatment. It could take up to 12 weeks to determine whether your medication is effective. The use of medication alone may not be enough to relieve all of your symptoms. There are also several nonpharmacologic treatments available, such as repetitive transcranial magnetic stimulation as well as vagus nerve stimulation. These therapies use electromagnetic fields in order to boost mood and stimulate the brain's chemical.

If you're considering psychotherapy or medication it is essential to be in close contact with your provider. Discuss your thoughts and feelings as well as the risks and potential side consequences that are associated with each. Find a practitioner who can meet your needs in case you're having difficulty building trust with your doctor or therapist. A provider who offers a free trial period could be a great option, since it gives you the opportunity to try different methods before making a commitment. In the end, you'll discover the treatment that is most effective for you and makes you feel and look your most at your best.

Brain stimulation

In just a few years, scientists have come up with new methods to target specific regions of the brain and swiftly alter the way they function. These techniques can be utilized to treat physical ailments as well as some mental disorders.

One approach is called rTMS, which employs electromagnetic pulses to stimulate the brain. It's similar to the magnetic impulses used in MRI however, it's not strong enough to trigger seizures. The technique is achieved by stimulating a specific part of the brain using an uninvolved magnet. The pulses alter the way that your brain processes and allow you to feel better. The treatment could take just 3.5 minutes and won't interfere with your daily activities. There may be a slight headache following the Treatment Refractory Depression (Speedgh.Com).

Another option is to implant electrodes into the brain to send painless electrical sparks. This treatment is also known as deep transcranial magnetic stimulation (deep TMS) and has been employed to treat OCD and to quit smoking cigarettes. It's still being studied for depression, but early studies suggest that it could reduce depressive symptoms in certain individuals. The mechanism behind this treatment isn't clear however it appears to be able to alter the balance of certain neurotransmitters.

Other forms of noninvasive brain stimulation are growing also. For example an upcoming study has found that patients with severe depression during pregnancy treatment who were resistant to antidepressants, responded to the treatment with magnetic pulses called SAINT. It's personalized to the specific anatomy of each patient's brain and relies on high-dose patterns of magnetic pulses. The treatment can be delivered in just a few hours, whereas previous treatments needed regular sessions for weeks or months.

Researchers used fMRI technology to pinpoint precisely the brain region being stimulated by every patient. They also examined the small differences in the way that the brain's various regions were activated, which allowed them to discern the direction of the signals. They found that the anterior cingulate cortical sent signals to the subgenual cortex of depressed people. However, these signals were often misdirected and the more severe the depression, the more of these signals that were not directed in the right direction were.